oncology - Nursing Case Study

Pathophysiology

• Primary mechanism: Uncontrolled Cell Proliferation - Cancer arises from mutations in genes that regulate cell growth and division. These mutations lead to the loss of normal cell cycle control, allowing cells to proliferate uncontrollably, forming tumors.

• Secondary mechanism: Evasion of Apoptosis - Cancer cells bypass programmed cell death, normally a safeguard against damaged or abnormal cells. This evasion contributes to tumor survival and resistance to therapies.

• Key complication: Metastasis - Cancer cells can invade surrounding tissues and spread to distant sites via the bloodstream or lymphatic system, complicating treatment and worsening prognosis.

Patient Profile

Demographics:

58-year-old female, retired school teacher

History:

• Key past medical history: Diagnosed with stage II breast cancer two years ago; underwent lumpectomy and completed chemotherapy

• Current medications: Tamoxifen 20 mg daily, Lisinopril 10 mg daily, Metformin 500 mg twice daily

• Allergies: Penicillin (rash)

Current Presentation:

• Chief complaint: Increasing shortness of breath and fatigue over the past week

• Key symptoms: Persistent cough, mild chest pain, loss of appetite, weight loss of 5 pounds in the last month

• Vital signs: Blood pressure 150/95 mmHg, heart rate 105 bpm, respiratory rate 24 breaths per minute, temperature 99.5°F, oxygen saturation 89% on room air

Section 1

Initial Assessment Findings:

Upon further assessment in the oncology clinic, the patient exhibits increased respiratory distress, with oxygen saturation persistently below 90% despite supplemental oxygen via nasal cannula. Auscultation of the lungs reveals decreased breath sounds and dullness to percussion over the right lower lobe, suggestive of a pleural effusion. The patient also reports increased fatigue, limiting her ability to perform activities of daily living. On physical examination, there is mild peripheral edema in the lower extremities and jugular venous distension, raising suspicion of potential cardiac involvement.

Laboratory investigations reveal anemia with a hemoglobin level of 9.2 g/dL, a white blood cell count of 12,000/µL indicating a possible inflammatory or infectious process, and elevated liver enzymes, which could suggest hepatic involvement. A chest X-ray is ordered and shows a large pleural effusion on the right side and possible nodular shadows in the lung parenchyma, raising concerns for metastatic spread of the breast cancer.

These findings, combined with the patient’s history of breast cancer, suggest a possible progression of the disease with metastasis to the lungs and potentially other systemic involvement. The oncology team is considering further diagnostic imaging, such as a CT scan of the chest and abdomen, to assess the extent of metastatic disease and guide the development of an adjusted treatment plan. This situation requires careful clinical reasoning to balance the management of current symptoms with the need to address the underlying oncological issues. The patient's journey is now at a critical juncture, where decisions made will impact her quality of life and overall prognosis.

Section 2

New Diagnostic Results:

Following the initial assessment, a CT scan of the chest and abdomen is performed, revealing significant findings that further illuminate the patient's condition. The CT scan confirms the presence of a large right-sided pleural effusion and identifies multiple nodules in both lungs, consistent with metastatic disease. Additionally, the scan shows enlarged mediastinal lymph nodes, indicating potential lymphatic involvement, and a suspicious lesion in the liver, suggesting hepatic metastasis. The oncology team also notes mild pericardial effusion, which correlates with the patient's jugular venous distension and raises concerns about potential cardiac tamponade.

In light of these findings, the patient's case is discussed in a multidisciplinary team meeting to evaluate the best course of action. The team considers initiating a thoracentesis to relieve the pleural effusion and improve respiratory function, which is critical given the patient's continued respiratory distress and low oxygen saturation levels despite supplemental oxygen. The possibility of a pericardiocentesis is also discussed to address the pericardial effusion and prevent hemodynamic compromise.

These results necessitate a careful re-evaluation of the patient's treatment plan. The oncology team considers introducing or modifying systemic therapy to target metastatic lesions, while also addressing supportive measures to manage symptoms and maintain quality of life. The patient is informed about the progression of her disease and the implications of the new findings, emphasizing the importance of a comprehensive approach that balances aggressive cancer treatment with palliative care to ensure comfort and stability. This pivotal moment in the patient's journey requires astute clinical reasoning to prioritize interventions and tailor management strategies effectively.

Section 3

Following the multidisciplinary team meeting, the patient undergoes a thoracentesis to alleviate the significant pleural effusion. This intervention provides immediate relief, as evidenced by improved respiratory function and increased oxygen saturation levels, now stabilizing at 92% on 2L of supplemental oxygen via nasal cannula. However, during the procedure, the patient experiences brief episodes of tachycardia and hypotension, with heart rate peaking at 115 beats per minute and blood pressure dropping to 90/60 mmHg. These fluctuations raise concerns about underlying hemodynamic instability, possibly exacerbated by the mild pericardial effusion.

In the subsequent days, the patient begins a modified systemic therapy regimen aimed at controlling the metastatic progression. Despite the treatment adjustments, the patient's condition exhibits further complications. She reports increasing fatigue and new-onset abdominal discomfort. A follow-up liver function test reveals elevated liver enzymes: ALT at 78 IU/L, AST at 85 IU/L, and alkaline phosphatase at 140 IU/L, suggesting hepatic involvement and potential progression of the suspicious liver lesion. Additionally, the patient shows signs of early cachexia with a notable weight loss of 2 kg within a week, despite efforts to maintain nutritional intake.

These developments prompt the oncology team to reassess the therapeutic approach, contemplating the balance between aggressive treatment and maintaining quality of life. The team considers integrating palliative care strategies more prominently to address the patient's symptom burden and improve her nutritional status. The case now pivots towards a more holistic management plan, emphasizing symptom control alongside ongoing cancer treatment. This approach requires careful monitoring and frequent reassessment to adapt to the patient's evolving clinical needs, ensuring her comfort and optimizing therapeutic outcomes.

Section 4

As the oncology team continues to monitor the patient closely, a new complication arises. The patient begins to experience worsening abdominal distension and pain, prompting further investigation. An abdominal ultrasound is performed, revealing moderate ascites and multiple small lesions scattered throughout the liver, suggestive of further metastatic spread. Additionally, the patient's serum albumin level has decreased to 2.8 g/dL, indicating potential malnutrition and contributing to the ascites. These findings necessitate a more aggressive approach to fluid management, including the possible use of diuretics and dietary modifications to address the hypoalbuminemia.

In response to these developments, the medical team adjusts the patient's care plan. Given the increased abdominal discomfort and risk of further nutritional decline, the focus shifts slightly more towards palliative measures. The patient is started on a low-volume, high-calorie nutritional supplement to support her energy needs while minimizing the risk of exacerbating her ascites. Pain management is also intensified, with the introduction of a low-dose opioid regimen to alleviate discomfort without significantly impacting her alertness or respiratory function.

The patient's vital signs remain relatively stable, with blood pressure hovering around 100/65 mmHg and heart rate maintaining at 105 beats per minute. However, the ongoing weight loss and fatigue highlight the need for integrative support, including physiotherapy to maintain muscle tone and energy expenditure. As the patient navigates this complex phase of her illness, the interdisciplinary team holds regular meetings to reassess treatment efficacy and symptom management strategies, ensuring that each step aligns with the patient's goals and enhances her quality of life. This coordinated approach fosters an environment where clinical reasoning is continuously applied to adapt the care plan as the patient's condition evolves.

Section 5

As the oncology team continues to tailor the care plan, the patient's response to the adjusted interventions begins to reveal new challenges. Within a week of initiating the low-dose opioid regimen and nutritional supplement, the patient exhibits a partial improvement in abdominal discomfort, reporting a decrease in pain severity from a 7 to a 5 on a 10-point scale. However, she also experiences increased drowsiness, a common side effect of opioid therapy, which raises concerns about her ability to participate fully in physiotherapy sessions. The team considers this trade-off and determines that the current pain management plan strikes an acceptable balance between relief and maintaining her quality of life.

Simultaneously, the patient's serum electrolyte panel indicates a mild hyponatremia, with sodium levels dropping to 132 mEq/L, likely influenced by the introduction of diuretics to manage her ascites. This finding necessitates a careful evaluation of her fluid and electrolyte balance. The team adjusts her diuretic therapy, opting for a more conservative dosing strategy and increasing her dietary sodium intake slightly, while monitoring her daily weights and fluid status closely. The goal is to mitigate the ascites without exacerbating the electrolyte imbalance, which could further impact her cognitive function and overall well-being.

Despite these adjustments, the patient's overall energy levels remain low, and there is a noted decline in her functional status, with her mobility decreasing due to persistent fatigue. The interdisciplinary team convenes to reassess her care priorities, emphasizing a palliative approach that focuses on comfort and dignity, as well as maintaining open communication with the patient and her family about realistic expectations. This ongoing dynamic assessment and adaptation of the care plan underscore the importance of clinical reasoning as the team navigates the complexities of her condition, ensuring that interventions are aligned with her evolving needs and preferences.